CG MedTech Co

CG MedTech Co AAQS

The The AAQS of CG MedTech Co (056090.KQ) as of Oct 18, 2026 is 3. In the previous year, The AAQS was 3.00 — a change of 0.00% (lower).

AAQS

3

YoY

0.00%

Last updated:

CG MedTech Co has a current AAQS of 3.

A high AAQS can be seen as a positive indicator that the company is developing successfully.

Investors can assume that the company is on a good path to generate profits.

On the other hand, it is important to consider the AAQS of the stock CG MedTech Co in comparison to the profits generated and other companies in the same industry. A high AAQS is not an absolute guarantee for a positive future. Only in this way can one get a complete picture of the company's performance.

In order to better assess the company's development, it is important to consider the AAQS in comparison to other companies in the same industry. In general, investors should always consider the AAQS of a company in connection with other fundamentals such as profit, EBIT, cash flow, and others in order to make an informed investment decision.

The CG MedTech Co AAQS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

AAQS
Date
AAQS
Jan 1, 2018
3.00 KRW
Jan 1, 2019
3.00 KRW
Jan 1, 2020
3.00 KRW
Jan 1, 2021
3.00 KRW
Jan 1, 2022
3.00 KRW
Jan 1, 2023
3.00 KRW
Jan 1, 2024
3.00 KRW
Jan 1, 2025
3.00 KRW
The CG MedTech Co AAQS history
YEARAAQSYoY
30.00%
30.00%
30.00%
30.00%
30.00%
30.00%
30.00%
30.00%
30.00%
30.00%
30.00%
3—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

CG MedTech Co Stock analysis

What does CG MedTech Co do? CG MedTech Co Ltd, listed on the Korea Exchange with ticker 056090.KQ and ISIN KR7056090004, is a company based in Uijeongbu, South Korea. It operates within the Health Care sector, specifically in the Health Care industry. The company went public on November 12, 2015. Its website is https://inno-sys.net/. CG MedTech Co Ltd focuses on the manufacture of orthopaedic surgical implants and surgical devices. The company's business activities are conducted through two segments: the Medical Device Business segment, which involves the production and sale of spinal fixation devices, micro-invasive medical devices for back pain treatment, fracture treatment devices, and bioabsorbable alloy implants, and the Electric Energy Business segment, which is involved in the production and sale of electricity meters and integrated calorimeters. The company's headquarters are located in Uijeongbu, Gyeonggi-Do. The website provided is associated with the company, though the source description mentions 'Innosys Co. Ltd.' as the company name, which may differ from the official name. The source also indicates that the company's IPO date is November 12, 2015, which aligns with the provided information. The company's operations are centered around medical devices, with a secondary focus on electric energy products. CG MedTech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about CG MedTech Co stock

The AAQS of CG MedTech Co is 3 in 2025.

On Eulerpool you can find the complete historical development of The AAQS CG MedTech Co since 2006 – with annual values, charts, and detailed analysis.

The AAQS is a key figure developed by AlleAktien.

The AAQS is a key figure developed by AlleAktien.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — CG MedTech Co

All Key Metrics — CG MedTech Co